History
  • No items yet
midpage
Davids v. Novartis Pharmaceuticals Corp.
977 F. Supp. 2d 171
E.D.N.Y
2013
Read the full case

Background

  • Davids sued Novartis for BRONJ linked to Zometa, alleging inadequate warnings, breach of implied warranty, and negligence.
  • A jury found in Davids’s favor on all three claims in 2012, awarding $450,000 compensatory and $10,000,000 punitive damages.
  • Davids died after trial; Newman moved to substitute as Executor, which the court granted unopposed.
  • The court proceeded to address four post-trial motions: mistrial over alleged extrinsic dictionary material, reduction of punitive damages, interest on judgment, and substitution of plaintiff.
  • The court previously held NJ punitive damages law applies, with a 5:1 cap pursuant to New Jersey Punitive Damages Act and NJPLA immunities when FDA labeling is compliant.
  • The court ultimately granted substitution, denied mistrial, reduced punitive damages to $900,000, and denied prejudgment interest on punitive damages.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Mistrial due to extrinsic juror material Davids/Pltf contends jurors used extrinsic material from a dictionary Novartis argues juror misconduct occurred, warranting new trial Mistrial/new trial denied; evidence too thin and hearsay-based
Whether punitive damages should be reduced Argues five-times compensatory is appropriate under NJPDA Challenges the ratio under due process and NJPDA Punitive damages reduced to $900,000 (double compensatory) after due process and NJPDA analysis
Prejudgment interest on punitive damages New Jersey law permits prejudgment interest on judgments New York law applies or interest on punitive damages disallowed pre-judgment Prejudgment interest denied on punitive damages under New Jersey law
Substitution of plaintiff Davids’s estate substituted as plaintiff is appropriate No opposition; substitution not contested Substitution granted; Ian Newman appointed Executor

Key Cases Cited

  • Campbell v. State Farm Mut. Auto. Ins. Co., 538 U.S. 408 (Sup. Ct. 2003) (three Gore guideposts for punitive damages; due process limits)
  • BMW of North America v. Gore, 517 U.S. 559 (Sup. Ct. 1996) (three guideposts for excessiveness of punitive damages)
  • Fagan v. AmerisourceBergen Corp., 356 F.Supp.2d 198 (E.D.N.Y. 2004) (reprehensibility and deterrence in punitive damages analysis)
  • Payne v. Jones, 711 F.3d 85 (2d Cir. 2013) (re ratio guidance when compensatory damages are substantial)
  • Kemp v. American Tel. & Tel. Co., 393 F.3d 1354 (11th Cir. 2004) (weight given to remedial comparison in punitive analysis)
  • DLC Mgmt. Corp. v. Town of Hyde Park, 163 F.3d 124 (2d Cir. 1998) (new trial standard; appellate deference to jury verdicts)
  • Belmont Condominium Ass’n, Inc. v. Geibel, 74 A.3d 10 (N.J. App. Div. 2013) (prejudgment interest on punitive damages not permitted in NJ)
  • Saffos v. Avaya Inc., 16 A.3d 1076 (N.J. App. Div. 2011) (N.J. factors for punitive damages are akin to Gore guideposts)
  • Song v. Ives Labs., Inc., 957 F.2d 1041 (2d Cir. 1992) (new trial standard; weighing evidence for Rule 59)
Read the full case

Case Details

Case Name: Davids v. Novartis Pharmaceuticals Corp.
Court Name: District Court, E.D. New York
Date Published: Oct 9, 2013
Citation: 977 F. Supp. 2d 171
Docket Number: No. 06-CV-431 (ADS)(WDW)
Court Abbreviation: E.D.N.Y